<VariationArchive VariationID="13658" VariationName="NM_006218.4(PIK3CA):c.3203dup (p.Asn1068fs)" VariationType="Duplication" Accession="VCV000013658" Version="3" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2017-04-21" MostRecentSubmission="2023-12-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="28697" VariationID="13658">
      <GeneList>
        <Gene Symbol="PIK3CA" FullName="phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha" GeneID="5290" HGNC_ID="HGNC:8975" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q26.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="179148126" stop="179240093" display_start="179148126" display_stop="179240093" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="178866310" stop="178952499" display_start="178866310" display_stop="178952499" Strand="+" />
          </Location>
          <OMIM>171834</OMIM>
          <Haploinsufficiency last_evaluated="2015-03-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PIK3CA">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-03-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PIK3CA">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006218.4(PIK3CA):c.3203dup (p.Asn1068fs)</Name>
      <CanonicalSPDI>NC_000003.12:179234358:AA:AAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3q26.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="179234358" stop="179234359" display_start="179234358" display_stop="179234359" variantLength="1" positionVCF="179234358" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="178952146" stop="178952147" display_start="178952146" display_stop="178952147" variantLength="1" positionVCF="178952146" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
      </Location>
      <ProteinChange>N1068fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_310t1" sequenceAccession="LRG_310t1" change="c.3203dup">
            <Expression>LRG_310t1:c.3203dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_310" sequenceAccession="LRG_310" change="g.90838dup">
            <Expression>LRG_310:g.90838dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.178952148dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.178952148dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.179234360dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.179234360dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012113.2" sequenceAccession="NG_012113" sequenceVersion="2" change="g.90838dup">
            <Expression>NG_012113.2:g.90838dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006218.4" sequenceAccession="NM_006218" sequenceVersion="4" change="c.3203dup" MANESelect="true">
            <Expression>NM_006218.4:c.3203dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006209.2" sequenceAccession="NP_006209" sequenceVersion="2" change="p.Asn1068fs">
            <Expression>NP_006209.2:p.Asn1068fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="587776802" DB="dbSNP" />
        <XRef ID="CA123341" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="171834.0007" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006218.4(PIK3CA):c.3203dup (p.Asn1068fs) AND Hepatocellular carcinoma" Accession="RCV000014641" Version="12">
        <ClassifiedConditionList TraitSetID="6315">
          <ClassifiedCondition DB="MedGen" ID="C2239176">Hepatocellular carcinoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2005-02-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006218.4(PIK3CA):c.3203dup (p.Asn1068fs) AND PIK3CA related overgrowth syndrome" Accession="RCV003458189" Version="1">
        <ClassifiedConditionList TraitSetID="23022">
          <ClassifiedCondition DB="MedGen" ID="C4728213">PIK3CA related overgrowth syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-21" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006218.4(PIK3CA):c.3203dup (p.Asn1068fs) AND Gastric cancer" Accession="RCV002508126" Version="8">
        <ClassifiedConditionList TraitSetID="25633">
          <ClassifiedCondition DB="MedGen" ID="C0024623">Gastric cancer</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2005-02-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-21" NumberOfSubmissions="3" NumberOfSubmitters="2" DateCreated="2017-04-21" MostRecentSubmission="2023-12-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15608678</ID>
        </Citation>
        <DescriptionHistory Dated="2023-12-23">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="25633" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="30012" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Malignant tumor of stomach</ElementValue>
                <XRef ID="363349007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Stomach cancer</ElementValue>
                <XRef ID="HP:0012126" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Gastric cancer</ElementValue>
                <XRef ID="HP:0012126" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0001056" DB="MONDO" />
              </Name>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Gastric Cancer, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng83</URL>
                <CitationText>UK NICE Guideline (NG83), Oesophago-gastric cancer: assessment and management in adults, 2023</CitationText>
              </Citation>
              <XRef ID="C0024623" DB="MedGen" />
              <XRef ID="D013274" DB="MeSH" />
              <XRef ID="MONDO:0001056" DB="MONDO" />
              <XRef Type="MIM" ID="613659" DB="OMIM" />
              <XRef Type="primary" ID="HP:0012126" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="23022" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="34372" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">PIK3CA related overgrowth syndrome</ElementValue>
                <XRef ID="737037004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PIK3CA-Related Segmental Overgrowth</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PIK3CA-associated segmental overgrowth</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PIK3CA related overgrowth spectrum</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">PIK3CA-related overgrowth spectrum (PROS) encompasses a range of clinical findings in which the core features are congenital or early-childhood onset of segmental/focal overgrowth with or without cellular dysplasia. Prior to the identification of PIK3CA as the causative gene, PROS was separated into distinct clinical syndromes based on the tissues and/or organs involved (e.g., MCAP [megalencephaly-capillary malformation] syndrome and CLOVES [congenital lipomatous asymmetric overgrowth of the trunk, lymphatic, capillary, venous, and combined-type vascular malformations, epidermal nevi, skeletal and spinal anomalies] syndrome). The predominant areas of overgrowth include the brain, limbs (including fingers and toes), trunk (including abdomen and chest), and face, all usually in an asymmetric distribution. Generalized brain overgrowth may be accompanied by secondary overgrowth of specific brain structures resulting in ventriculomegaly, a markedly thick corpus callosum, and cerebellar tonsillar ectopia with crowding of the posterior fossa. Vascular malformations may include capillary, venous, and less frequently, arterial or mixed (capillary-lymphatic-venous or arteriovenous) malformations. Lymphatic malformations may be in various locations (internal and/or external) and can cause various clinical issues, including swelling, pain, and occasionally localized bleeding secondary to trauma. Lipomatous overgrowth may occur ipsilateral or contralateral to a vascular malformation, if present. The degree of intellectual disability appears to be mostly related to the presence and severity of seizures, cortical dysplasia (e.g., polymicrogyria), and hydrocephalus. Many children have feeding difficulties that are often multifactorial in nature. Endocrine issues affect a small number of individuals and most commonly include hypoglycemia (largely hypoinsulinemic hypoketotic hypoglycemia), hypothyroidism, and growth hormone deficiency.</Attribute>
                <XRef ID="NBK153722" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23946963</ID>
                <ID Source="BookShelf">NBK153722</ID>
              </Citation>
              <Citation Type="general">
                <ID Source="PubMed">27631024</ID>
              </Citation>
              <XRef ID="530313" DB="Orphanet" />
              <XRef ID="C4728213" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6315" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="18496" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hepatocellular carcinoma</ElementValue>
                <XRef ID="HP:0001402" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0007256" DB="MONDO" />
                <XRef ID="25370001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Primary carcinoma of liver</ElementValue>
                <XRef ID="187769009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hepatoma</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">LIVER CELL CARCINOMA</ElementValue>
                <XRef Type="MIM" ID="114550" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hepatocellular cancer</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HCC</ElementValue>
                <XRef Type="MIM" ID="114550" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LCC</ElementValue>
                <XRef Type="MIM" ID="114550" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16773" />
                <XRef ID="16773" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/hcc.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Hepatocellular Carcinoma, 2024</CitationText>
              </Citation>
              <XRef ID="88673" DB="Orphanet" />
              <XRef ID="C2239176" DB="MedGen" />
              <XRef ID="MONDO:0007256" DB="MONDO" />
              <XRef Type="MIM" ID="114550" DB="OMIM" />
              <XRef Type="primary" ID="HP:0001402" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002899" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0003007" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006750" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="34897" SubmissionDate="2017-04-13" DateLastUpdated="2017-04-21" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="171834.0007_GASTRIC CANCER, SOMATIC" title="PIK3CA, 1-BP INS, 3204A_GASTRIC CANCER, SOMATIC" />
        <ClinVarAccession Accession="SCV000034897" DateUpdated="2017-04-21" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-02-17">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>somatic</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In tissue samples from 13 (50%) of 26 hepatocellular carcinomas (114550) with PIK3CA mutations, Lee et al. (2005) identified a 1-bp insertion (3204insA) in exon 20 of the PIK3CA gene, resulting in a frameshift. One gastric cancer (137215) tumor also carried the mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">15608678</ID>
              </Citation>
              <XRef DB="OMIM" ID="114550" Type="MIM" />
              <XRef DB="OMIM" ID="137215" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PIK3CA" />
          </GeneList>
          <Name>PIK3CA, 1-BP INS, 3204A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 3204A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="171834.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">GASTRIC CANCER, SOMATIC</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="34896" SubmissionDate="2017-04-13" DateLastUpdated="2017-04-21" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="171834.0007_HEPATOCELLULAR CARCINOMA, SOMATIC" title="PIK3CA, 1-BP INS, 3204A_HEPATOCELLULAR CARCINOMA, SOMATIC" />
        <ClinVarAccession Accession="SCV000034896" DateUpdated="2017-04-21" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-02-17">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>somatic</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In tissue samples from 13 (50%) of 26 hepatocellular carcinomas (114550) with PIK3CA mutations, Lee et al. (2005) identified a 1-bp insertion (3204insA) in exon 20 of the PIK3CA gene, resulting in a frameshift. One gastric cancer (137215) tumor also carried the mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">15608678</ID>
              </Citation>
              <XRef DB="OMIM" ID="114550" Type="MIM" />
              <XRef DB="OMIM" ID="137215" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PIK3CA" />
          </GeneList>
          <Name>PIK3CA, 1-BP INS, 3204A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 3204A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="171834.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HEPATOCELLULAR CARCINOMA, SOMATIC</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7816646" SubmissionDate="2023-12-12" DateLastUpdated="2023-12-24" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="NM_006218.4:c.3203dup|PIK3CA-related overgrowth syndrome" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004176955" DateUpdated="2023-12-24" DateCreated="2023-12-24" Type="SCV" Version="1" SubmitterName="Clinical Genomics Laboratory, Washington University in St. Louis" OrgID="505219" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The PIK3CA c.3203dup (p.Asn1068LysfsTer5) variant was identified at an allelic fraction consistent with somatic origin. This variant has been reported in individuals with lung, breast, liver, and bladder cancers (Youssef O et al., PMID: 2819998; Miron A et al., PMID: 20551053; Cizkova Met al., PMID: 22330809; Kachrilas S et al., PMID: 30941989); however, to our knowledge, this variant has not been reported in individuals affected with PIK3CA-Related Overgrowth Spectrum (PROS) disorders. This variant has been reported in multiple cases in the cancer database COSMIC (Genomic Mutation ID: COSV55878665). The PIK3CA c.3203dup (p.Asn1068LysfsTer5) variant is absent from the general population (gnomAD v.2.1.1), indicating it is not a common variant. The PIK3CA c.3203dup (p.Asn1068LysfsTer5) variant resides within the C-terminal chain, A1052-A1068, of PIK3CA. This variant results in increased cell proliferation, migration, and Akt phosphorylation compared to wild-type gene product and increased transformation ability in several different cell lines in culture (Jin N et al., PMID: 34779417; Ng PK et al., PMID: 29533785). This variant causes a frameshift by duplicating a single nucleotide; however, because this occurs in the last exon, this is not predicted to lead to nonsense-mediated decay. A large number of PI3K/AKT pathway inhibitors are currently under clinical study in both PROS disorders and cancer (Jin N et al., PMID: 34779417; Venot Q et al., PMID: 29899452; Parker VER et al., PMID: 30270358). Based on an internally-developed protocol informed by the ACMG/AMP guidelines (Richards S et al., PMID: 25741868) and gene-specific practices from the ClinGen Criteria Specification Registry, the PIK3CA c.3203dup (p.Asn1068LysfsTer5) variant is classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>somatic</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006218.4:c.3203dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PIK3CA-related overgrowth syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14038946</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="34897" TraitType="Disease" MappingType="Name" MappingValue="GASTRIC CANCER, SOMATIC" MappingRef="Alternate">
        <MedGen CUI="C0024623" Name="Gastric cancer" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7816646" TraitType="Disease" MappingType="Name" MappingValue="PIK3CA-related overgrowth syndrome" MappingRef="Preferred">
        <MedGen CUI="C4728213" Name="PIK3CA related overgrowth syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="34896" TraitType="Disease" MappingType="Name" MappingValue="HEPATOCELLULAR CARCINOMA, SOMATIC" MappingRef="Preferred">
        <MedGen CUI="C2239176" Name="Hepatocellular carcinoma" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

